Uroplasty, Inc. (Amex:
UPI), a medical device company that develops, manufactures and markets
innovative proprietary products for the treatment of voiding dysfunction,
announced that the Urgent(R) PC Neuromodulation System, its
proprietary, minimally invasive nerve stimulation device, designed for
office-based treatment of overactive bladder (OAB) symptoms, will be
featured in three presentations at the Society of Urologic Nurses and
Associates (SUNA) Annual Symposium. SUNA will be held at the Marriott
Waterside Hotel and Marina in Tampa, Florida from Thursday, February 28,
through Sunday, March 2. These retrospective and observational studies
examined the use of Urgent(R) PC Neuromodulation System to deliver the
percutaneous tibial nerve stimulation (PTNS) for the treatment of OAB
symptoms of urinary urgency, urinary frequency, and urge incontinence. The
Company will present a summary of these presentations on Monday, March 3
before the market opens. The schedule for the oral presentation and
poster-discussion sessions is as follows:
-- Leslie Wooldridge, MSN, RNCS, GNP.F, BCIA-PMBD, Director of the Bladder
Control Clinic, Hackley Health at the Lakes Women's Center, Muskegon,
Michigan, "Percutaneous Tibial Nerve Stimulation: Revival of an Old
Technology for Treatment of Overactive Bladder," Sunday, March 2, at 8
am, oral presentation
-- Vanessa K. Hardy, WHNP, APN, MSN, Nurse Practitioner, Urogynecology,
Vanderbilt University Medical Center, Nashville, Tennessee,
"Percutaneous Tibial Nerve Stimulator: A Viable Option for Urgency,
Frequency, and Urge Incontinence," Friday, February 29 through
Saturday, March 1, poster presentation
-- Lesbia Candelaria, RN, Winter Park Urology Associates, Orlando,
Florida, "Percutaneous Tibial Nerve Stimulation (PTNS) Treatment for
Overactive Bladder (OAB) Patients in a Community Based Urology
Practice," Friday, February 29 through Saturday, March 1, poster
presentation
About the Urgent PC Neuromodulation System
The Urgent PC neuromodulation system is a proprietary, minimally
invasive nerve stimulation device designed for office-based treatment of
OAB symptoms of urge incontinence, urinary urgency and urinary frequency.
Application of neuromodulation therapy targets specific nerve tissue and
disrupts the signals that lead to the symptoms of OAB. Uroplasty sells the
Urgent PC system in the United States, Canada and countries recognizing the
CE mark. Outside of the United States, the Urgent PC is also indicated for
the treatment of fecal incontinence.
About Uroplasty, Inc.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with
wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a
medical device company that develops, manufactures and markets innovative
proprietary products for the treatment of voiding dysfunctions. Our primary
focus is the commercialization of our Urgent PC system, which we believe is
the only FDA- approved non-surgical neurostimulation therapy for the
treatment of overactive bladder (OAB) symptoms. We also offer
Macroplastique(R) Implants, a bulking agent for the treatment of urinary
incontinence. Please visit Uroplasty, Inc. at uroplasty.
Uroplasty, Inc.
uroplasty